Compare TVTX & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVTX | LXP |
|---|---|---|
| Founded | N/A | 1993 |
| Country | United States | United States |
| Employees | N/A | 58 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2013 | N/A |
| Metric | TVTX | LXP |
|---|---|---|
| Price | $28.06 | $48.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $36.85 | ★ $52.83 |
| AVG Volume (30 Days) | ★ 1.3M | 619.0K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.77% |
| EPS Growth | ★ 92.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.75 | $1.71 |
| Revenue Next Year | $26.82 | $8.03 |
| P/E Ratio | ★ N/A | $26.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.91 | $6.85 |
| 52 Week High | $42.13 | $52.52 |
| Indicator | TVTX | LXP |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 44.98 |
| Support Level | $27.01 | $47.35 |
| Resistance Level | $31.47 | $51.69 |
| Average True Range (ATR) | 1.64 | 1.56 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 25.89 | 33.10 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.